Concepedia

Khedidja Bouachi

KB

Statistics

Publications

6

Citations

483

H-Index

6

Active since

2013

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Inserm

Université Paris-Est Créteil

Sorbonne Université

Pitié-Salpêtrière Hospital

Khedidja Bouachi is an author at Assistance Publique – Hôpitaux de Paris specializing in renal disease, medicine, and podocyte injury.

Publications per year

2013–2020

6

Publications

6

Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease

Hélène Munyentwali, Khedidja Bouachi, Vincent Audard et al. · Kidney International · 2013 · 153 citations

, , +4

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

, , +6

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

Hassan Izzedine, M. Mangier, Virginie Ory et al. · Kidney International · 2013 · 102 citations · Full text

, , +17

Upregulation of c-mip is closely related to podocyte dysfunction in membranous nephropathy

Kélhia Sendeyo, Vincent Audard, Shaoyu Zhang et al. · Kidney International · 2013 · 37 citations · Full text

, , +12

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study)

Philippe Rémy, Vincent Audard, Pierre André Natella et al. · Kidney International · 2018 · 29 citations

, , +14

1–5 of 6